Navigation Links
Shock for Life and HeartSine® Technologies Now Exclusive Providers of Lifesaving AED Solution to Wegmans Food Markets
Date:8/30/2011

NEWTOWN, Pa., Aug. 30, 2011 /PRNewswire/ -- HeartSine® Technologies, Inc. (www.heartsine.com), a world leader in personal and public access defibrillators, announced today that Wegmans Food Markets, Inc. has selected  the HeartSine Automated External Defibrillator (AED) as the exclusive AED in its facilities.  

Wegmans Food Markets, Inc. is a major regional supermarket chain and one of the largest private companies in the U.S. with 2010 annual sales of $5.6 billion and over 41,000 employees.

By the end of 2011, the HeartSine samaritan® PAD 300P Public Access Defibrillator will be available in all 79 Wegmans stores should an employee or customer suffer from Sudden Cardiac Arrest (SCA). Designed for use on children and adults, its simple two-button operation and voice/visual prompts with clear instructions will guide rescuers through every step, including pad application, shock delivery and CPR.

Each Wegmans store ranges from 80,000 to 140,000 square feet in size. As part of the implementation, a comprehensive evaluation of each Wegmans store has been conducted, including the parking lots. This will help to ensure that a HeartSine PAD is easily accessible in a cardiac arrest emergency.

Quick response times are critical for the best possible outcome for recovery. When sudden cardiac arrest happens, the American Heart Association recommends that defibrillation treatment begin within three minutes. After 5 minutes and every minute thereafter, a victim loses 10% of their brain function due to loss of oxygen. According to the Centers for Disease Control and Prevention (CDC), a SCA event occurs once every 34 seconds.

"The criteria that companies look for when selecting a viable AED program include a comprehensive training solution, exceptional lifesaving technology, best-in-class reliability, product durability, and ease of use for their employees," said Marc Lawrence, HeartSine senior vice president. "The HeartSine samaritan PAD exceeds these criteria with the highest clinical standards backed by years of research and innovation. Our superior technology, 10-year warranty and 4-year Pad Pak™ life provides our clients with the power to save a life, at the lowest overall cost of ownership."

Shock for Life, a channel partner of HeartSine products and an American Heart Association authorized training center, is responsible for installation of the AED devices in Wegmans stores and for training employees on how to use the HeartSine 300P PAD to administer lifesaving treatment.  

"Our nationally standardized training program follows American Heart Association guidelines," said MaryBeth Barber, RN, BSN, CEO, Shock for Life. "For the Wegmans implementation, we'll be conducting 'Hands On' CPR/AED training in all of their stores, teaching employees how to recognize and care for breathing and cardiac emergencies, and how to use the HeartSine defibrillator for treatment."

Wegmans stores are located in New York, Pennsylvania, New Jersey, Virginia, and Maryland.  Its first New England store will open in Northborough, Massachusetts in October 2011. The family-owned company, founded in 1916, is recognized as an industry leader and innovator. Wegmans has been named one of the '100 Best Companies to Work For' by FORTUNE magazine for fourteen consecutive years. In 2011, Wegmans ranked #3 on the list.

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It's lifesaving, pure and simple.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Download a high-res photo of the samaritan® PAD 300P: http://www.ggcomm.com/HeartSine/PAD300P.jpg

121 Friends Lane
Suite 400
Newtown, PA 18940
Phone: 215.860.8100, ext. 112
Contact: Stacey Lock
stacey.lock@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
2. US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications
3. Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health
4. Shockwave System Developed to Aid Concussion Detection
5. Sepsis and Septic Shock on the Rise, Affecting Younger Patients
6. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
7. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
8. HeartSine® Technologies Donates Lifesaving AED to Camphill Special School
9. HeartSine® Increases AED System Warranty to Longest in the Industry
10. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
11. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... The Georgia State University College of Law new ... Urban Design Commission. , The annual award recognizes projects, programs, individuals and organizations that ... preservation of its physical heritage and the balance between the old and the new. ...
(Date:5/25/2016)... ... 2016 , ... A new update to Xsens popular data analysis ... a common Wi-Fi network and a mobile device. When paired with Xsens MVN or ... and use a mobile device to control the recording. , “The update adds ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... One Florida-based ... potential patients, according to an article published May 13th on Vanity Fair. ... comfortable with having snippets of their procedures broadcast to more than 800,000 Snapchat fans. ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Bank of America Charitable Foundation has awarded ... provide veterans a pathway to employment and successful careers in healthcare. On Wednesday, May ... Hallack, President and CEO of Medisend, parent organization and home of the General Myers ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies ... of injured workers across 15 states. The outcomes examined in these studies include ... medical care, and satisfaction with medical care. , “The goal of the studies ...
Breaking Medicine News(10 mins):